WallStSmart

Covista Inc. (CVSA)vsRuanyun Edai Technology Inc. Ordinary shares (RYET)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 28153% more annual revenue ($1.89B vs $6.69M). CVSA leads profitability with a 13.4% profit margin vs -5.9%. CVSA earns a higher WallStSmart Score of 67/100 (B-).

CVSA

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 8.3Quality: 5.0

RYET

Avoid

15

out of 100

Grade: F

Growth: 2.7Profit: 3.0Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -3.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CVSASignificantly Overvalued (N/A)

Margin of Safety

N/A

Fair Value

$97.23

Current Price

$113.08

$15.85 premium

UndervaluedFair: $97.23Overvalued

Intrinsic value data unavailable for RYET.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA4 strengths · Avg: 8.0/10
PEG RatioValuation
0.818/10

Growing faster than its price suggests

P/E RatioValuation
16.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

RYET1 strengths · Avg: 10.0/10
Debt/EquityHealth
-27.2510/10

Conservative balance sheet, low leverage

Areas to Watch

CVSA1 concerns · Avg: 4.0/10
EPS GrowthGrowth
4.7%4/10

4.7% earnings growth

RYET4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$34.69M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
2.8%3/10

Operating margin of 2.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bull Case : RYET

The strongest argument for RYET centers on Debt/Equity.

Bear Case : CVSA

The primary concerns for CVSA are EPS Growth.

Bear Case : RYET

The primary concerns for RYET are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

CVSA profiles as a value stock while RYET is a turnaround play — different risk/reward profiles.

CVSA is growing revenue faster at 12.4% — sustainability is the question.

CVSA generates stronger free cash flow (15M), providing more financial flexibility.

Monitor EDUCATION & TRAINING SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CVSA scores higher overall (67/100 vs 15/100) and 12.4% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Ruanyun Edai Technology Inc. Ordinary shares

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · China

Ruanyun Edai Technology Inc. is a data driven artificial intelligence technology company focused on kindergarten through year twelve education (K-12) in China. The company is headquartered in Nanchang, China.

Visit Website →

Want to dig deeper into these stocks?